.

Deeper Knowledge, Faster

  • Find suppliers and generic API sources
  • Predict branded drug patent expiration
  • Drug patents and clinical trials in dozens of countries

► See Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Johnson and Johnson
Mallinckrodt
Baxter
Cipla
US Army
Cerilliant
Fuji
Citi
Queensland Health
Harvard Business School

Generated: June 23, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 065229

« Back to Dashboard
NDA 065229 describes CEPHALEXIN, which is a drug marketed by Teva, Sun Pharm Inds Ltd, Purepac Pharm, Belcher Pharms, Hikma, Facta Farma, Orchid Hlthcare, Barr, Lupin, Alkem Labs Ltd, Yung Shin Pharm, Hikma Pharms, Aurobindo Pharma Ltd, Apothecon, Vitarine, Ivax Sub Teva Pharms, Stevens J, Yoshitomi, and Sun Pharm Inds (in), and is included in forty-nine NDAs. It is available from fifty-eight suppliers. Additional details are available on the CEPHALEXIN profile page.

The generic ingredient in CEPHALEXIN is cephalexin. There are twenty-nine drug master file entries for this compound. Sixty-one suppliers are listed for this compound. Additional details are available on the cephalexin profile page.

Summary for NDA: 065229

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:1
Therapeutic Class:Antibacterials
Formulation / Manufacturing:see details

Pharmacology for NDA: 065229

Ingredient-typeCephalosporins

Suppliers and Packaging for NDA: 065229

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
CEPHALEXIN
cephalexin
 CAPSULE;ORAL 065229 ANDA Blenheim Pharmacal, Inc. 10544-013 10544-013-28 28 CAPSULE in 1 BOTTLE (10544-013-28)
CEPHALEXIN
cephalexin
 CAPSULE;ORAL 065229 ANDA Blenheim Pharmacal, Inc. 10544-013 10544-013-40 40 CAPSULE in 1 BOTTLE (10544-013-40)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:CAPSULE;ORALStrengthEQ 250MG BASE
Approval Date:Nov 25, 2005TE:ABRLD:No

Summary for product number 002

Active Rx/OTC/Discontinued:RXDosage:CAPSULE;ORALStrengthEQ 500MG BASE
Approval Date:Nov 25, 2005TE:ABRLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Fish and Richardson
Dow
Federal Trade Commission
QuintilesIMS
Harvard Business School
McKesson
UBS
Healthtrust
Citi
Cantor Fitzgerald

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Related Products from thinkBiotech
Links

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot